0001062993-18-001676.txt : 20180417
0001062993-18-001676.hdr.sgml : 20180417
20180417111851
ACCESSION NUMBER: 0001062993-18-001676
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20180417
DATE AS OF CHANGE: 20180417
EFFECTIVENESS DATE: 20180417
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Invictus MD Strategies Corp.
CENTRAL INDEX KEY: 0001737647
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0131
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-310328
FILM NUMBER: 18758234
BUSINESS ADDRESS:
STREET 1: P.O. BOX 71567
STREET 2: HILLCREST PO
CITY: WHITE ROCK
STATE: A1
ZIP: V4B 5J5
BUSINESS PHONE: 604-512-2959
MAIL ADDRESS:
STREET 1: P.O. BOX 71567
STREET 2: HILLCREST PO
CITY: WHITE ROCK
STATE: A1
ZIP: V4B 5J5
D
1
primary_doc.xml
X0708
D
LIVE
0001737647
Invictus MD Strategies Corp.
HILLCREST PO P.O. BOX 71567
WHITE ROCK
A1
BRITISH COLUMBIA, CANADA
V4B 5J5
604-512-2959
BRITISH COLUMBIA, CANADA
BioAB Strategies Ltd.
None
Corporation
true
2014
Dan
Kriznic
Suite 3123
595 Burrard Street
Vancouver
A1
BRITISH COLUMBIA, CANADA
V7X 1J1
Executive Officer
Director
Trevor
Dixon
Suite 3123
595 Burrard Street
Vancouver
A1
BRITISH COLUMBIA, CANADA
V7X 1J1
Executive Officer
Director
George
Kveton
Suite 3123
595 Burrard Street
Vancouver
A1
BRITISH COLUMBIA, CANADA
V7X 1J1
Director
Aaron
Bowden
Suite 3123
595 Burrard Street
Vancouver
A1
BRITISH COLUMBIA, CANADA
V7X 1J1
Director
Josef
W
Hocher
Suite 1250 Millenium Tower
440 - 2nd Avenue SW
Calgary
A0
ALBERTA, CANADA
T2P 5E9
Director
Paul
Sparkes
151 Bloor Street West
Suite 810
Toronto
A6
ONTARIO, CANADA
M5S 1S4
Director
Dylan
Easterbrook
300
15047 Marine Drive
White Rock
A1
BRITISH COLUMBIA, CANADA
V4B 1C5
Executive Officer
Brenda
Dixon
Suite 3123
595 Burrard Street
Vancouver
A1
BRITISH COLUMBIA, CANADA
V7X 1J1
Executive Officer
Other
Decline to Disclose
- 06b
false
2018-03-14
false
true
Purch & Sale Agmt to acquire all outstndng shs of Gene-Etics Strains Co. for $2,500,000USD cash & 2,631,141 cmn shs of issuer at closing & 1,973,355 shares 180 days post close & 1,973,355 on later of 240 days post close or 1/2/2019 @$1.94 per sh
false
0
12516816
6506728
6010088
Purch & Sale Agmt to acquire all outstndng shs of Gene-Etics Strains Co. for $2,500,000USD cash & 2,631,141 cmn shs of issuer at closing & 1,973,355 shares 180 days post close & 1,973,355 on later of 240 days post close or 1/2/2019 @$1.94 per sh
false
1
0
0
0
false
Invictus MD Strategies Corp.
/s/ Dylan Easterbrook
Dylan Easterbrook
Chief Financial Officer
2018-04-13